Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+22.9%
5Y CAGR+17.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+22.9%/yr
vs +14.1%/yr prior
5Y CAGR
+17.9%/yr
Recent acceleration
Acceleration
+8.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.75B | +19.7% |
| 2024 | $1.46B | +28.8% |
| 2023 | $1.14B | +20.3% |
| 2022 | $944.70M | +12.5% |
| 2021 | $840.10M | +9.0% |
| 2020 | $770.50M | +17.0% |
| 2019 | $658.50M | +18.1% |
| 2018 | $557.62M | +12.4% |
| 2017 | $496.08M | +14.6% |
| 2016 | $432.83M | - |